Literature DB >> 22543539

Management of comorbidities in ankylosing spondylitis.

James Rosenbaum1, Vinod Chandran.   

Abstract

The major comorbidities of ankylosing spondylitis include uveitis, bowel inflammation, psoriasis and heart disease. The pathogenic mechanism to account for the coexistence of comorbidities remains largely unknown. In some instances, the comorbidity has a major impact on the choice of therapy.

Entities:  

Mesh：

Year:  2012        PMID： 22543539     DOI： 10.1097/MAJ.0b013e3182514059

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  14 in total

Review 1.  Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.

Authors:  Bashaar Alibrahim; Mohammed I Aljasser; Baljinder Salh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

Review 2.  The microbiome and HLA-B27-associated acute anterior uveitis.

Authors:  James T Rosenbaum; Mark Asquith
Journal:  Nat Rev Rheumatol       Date:  2018-12       Impact factor: 20.543

Review 3.  Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.

Authors:  James T Rosenbaum
Journal:  Clin Rheumatol       Date:  2015-05-08       Impact factor: 2.980

Review 4.  The Efficacy and Safety of Simple-Needling Therapy for Treating Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yichen Xuan; Hui Huang; Yiyong Huang; Duanyong Liu; Xiuwu Hu; Lele Geng
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-13       Impact factor: 2.629

5.  Turkish League Against Rheumatism Consensus Report: Recommendations For Management of Axial Spondyloarthritis.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Şebnem Ataman; Yeşim Garip; Kemal Nas; Fikriye Figen Ayhan Fikriye Figen Ayhan; Özgür Akgül; Ayşen Akinci; Zuhal Altay; Murat Birtane; Derya Soy Buğdayci; Erhan Çapkin; Remzi Çevik; Tuncay Duruöz; Gülcan Gürer; Cahit Kaçar; Ayhan Kamanli; Ece Kaptanoğlu; Taciser Kaya; Hilal Kocabaş; Ömer Kuru; Meltem Alkan Melikoğlu; Erhan Özdemirel; Sumru Özel; Aylin Rezvani; İlhan Sezer; İsmihan Sunar; Gürkan Yilmaz
Journal:  Arch Rheumatol       Date:  2018-02-14       Impact factor: 1.472

6.  Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study.

Authors:  Franziska G Matzkies; Stephan R Targan; Dror Berel; Carol J Landers; John D Reveille; Dermot P B McGovern; Michael H Weisman
Journal:  Arthritis Res Ther       Date:  2012-11-29       Impact factor: 5.156

7.  Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials.

Authors:  Joachim Sieper; Benjamin Porter-Brown; Liz Thompson; Olivier Harari; Maxime Dougados
Journal:  Ann Rheum Dis       Date:  2013-06-13       Impact factor: 19.103

8.  Clinical features of Crohn disease concomitant with ankylosing spondylitis: A preliminary single-center study.

Authors:  Song Liu; Jie Ding; Meng Wang; Wanqing Zhou; Min Feng; Wenxian Guan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  Severe bone marrow edema on sacroiliac joint MRI increases the risk of low BMD in patients with axial spondyloarthritis.

Authors:  Ha Neul Kim; Joon-Yong Jung; Yeon Sik Hong; Sung-Hwan Park; Kwi Young Kang
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

10.  Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set.

Authors:  Jessica A Walsh; Xue Song; Gilwan Kim; Yujin Park
Journal:  J Pharm Health Serv Res       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.